Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03707652 · ClinicalTrials.gov registry record · NA
Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)
A NA study, sponsored by Supplement Formulators.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03707652 is a NA study that has completed, run by Supplement Formulators. The registered enrollment target is 8 participants.
The verdict
NCT03707652, a NA study, has completed, sponsored by Supplement Formulators.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to assess an effective single oral supplement or combination of oral supplements for increasing whole blood NAD+ levels.
Interventions
- DIETARY_SUPPLEMENT Oral supplement A
- DIETARY_SUPPLEMENT Oral supplement B
- DIETARY_SUPPLEMENT Oral supplement C
- DIETARY_SUPPLEMENT Oral supplement D
- DIETARY_SUPPLEMENT Oral Supplement D in combination with oral supplement C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-03-12 |
| Est. Completion | 2018-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03707652
The ClinicalTrials.gov registry entry for NCT03707652 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Supplement Formulators, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Oral supplement A is the first listed.
NCT03707652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03707652 about?
NCT03707652 is a clinical study titled "Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)". The purpose of this study is to assess an effective single oral supplement or combination of oral supplements for increasing whole blood NAD+ levels.
What is the current status of trial NCT03707652?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2018-03-12. Estimated completion is 2018-05-24.
What interventions are being tested in trial NCT03707652?
The interventions under investigation include: Oral supplement A (DIETARY_SUPPLEMENT), Oral supplement B (DIETARY_SUPPLEMENT), Oral supplement C (DIETARY_SUPPLEMENT), Oral supplement D (DIETARY_SUPPLEMENT), Oral Supplement D in combination with oral supplement C (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03707652?
This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.